Adenosine Injection, Solution
Product Images NDC 67457-856

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Adenosine (NDC 67457-856). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Image 01)

FDA Label Image

20 mL Carton (Image 02)

20 mL Carton (Image 02)
Adenosine Injection, USP is a medication that contains Adenosine, USP (3 mg) and sodium chloride (8 mg) in each mL of sterile, nonpyrogenic and preservative-free solution for intravenous infusion. The container closure is not made with natural rubber latex. The usual dosage is described in the package insert. It should be stored between 20-25°C (88°F-77°F) with excursions permitted between 15-30°C (59°F-86°F). It is important to avoid refrigeration as crystalization may occur, and if that happens, the crystals should be dissolved by warming to body temperature. This medicine should be discarded after use. The National Drug Code (NDC) number of this product is 67457-856-20.*
FDA Label Image

30 mL Carton (Image 03)

30 mL Carton (Image 03)
This is a medication called Adenosine Injection, USP, which is sterile, non-pyrogenic, and does not contain preservatives. The container closure is not made with natural rubber latex. It is intended for intravenous infusion only, with a usual dosage described in the package insert. Each mL contains 3 mg of Adenosine, USP and 9 mg of sodium chloride in water for injection. The pH of the solution is between 4.5 and 7.5. This product should be stored at 20°C to 25°C. Excursions are permitted between 15°C and 30°C. Do not refrigerate because crystallization may occur, and if crystallization occurs, dissolve crystals by warming to room temperature. The solution must be clear at the time of use. The unused portion should be discarded. Some manufacturing information, regulatory numbers, and contact information are also provided.*
FDA Label Image

Structural Formula (Image 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.